Verisure plc/ADR
No enriched coverage for $VSRPF in the last 7 days.
No SEC Form 4 filings for $VSRPF in the last 30 days.
See all $VSRPF insider activity →Verisure reported Q3 2026 results with ARR of €3,712m (+11.8% y/y), Adjusted EBIT of €285m (+13.9% y/y), and Free Cash Flow of €59m. Customer base grew 9.0% y/y to 6.5m. The company expects 2026 ARR growth of 9.0%-9.5% and Adjusted EBIT margin around 26.5%. CEO Austin Lally highlighted strong profitability and cash generation.
Verisure Plc's stock rose 12% to 10.49 after reports that CVC is considering a potential offer to take the company private. The stock had fallen from its IPO price of 13.25, and analysts' average price target is above current levels. Hellman & Friedman owns 43.6% of Verisure. The broader market is down, contrasting with Verisure's surge.
Chevron is selling mature Gulf of Mexico assets to reduce future cleanup costs and maintenance spending, allowing it to focus on larger projects. Applus+ may sell its vehicle inspection unit for around €1 billion. CVC is exploring a takeover of Swedish-listed Verisure. Cencora will acquire American Oncology Network for up to $2.4 billion, expanding its US cancer care reach.
Recent VSRPF coverage spans earnings, market movers and corporate actions.
Verisure reported Q3 2026 results with ARR of €3,712m (+11.8% y/y), Adjusted EBIT of €285m (+13.9% y/y), and Free Cash Flow of €59m. Customer base grew 9.0% y/y to 6.5m. The company expects 2026 ARR growth of 9.0%-9.5% and Adjusted EBIT margin around 26.5%. CEO Austin Lally highlighted strong profitability and cash generation.
Verisure Plc's stock rose 12% to 10.49 after reports that CVC is considering a potential offer to take the company private. The stock had fallen from its IPO price of 13.25, and analysts' average price target is above current levels. Hellman & Friedman owns 43.6% of Verisure. The broader market is down, contrasting with Verisure's surge.
Chevron is selling mature Gulf of Mexico assets to reduce future cleanup costs and maintenance spending, allowing it to focus on larger projects. Applus+ may sell its vehicle inspection unit for around €1 billion. CVC is exploring a takeover of Swedish-listed Verisure. Cencora will acquire American Oncology Network for up to $2.4 billion, expanding its US cancer care reach.
Goldman Sachs reduced its price target for Verisure from €15 to €13 but maintained a 'buy' rating. The stock is currently trading at €8.115, reflecting a 40.86% decline year-to-date. The company recently expanded its AI-powered GuardVision Outdoor Video Detector internationally.
Verisure PLC reported Q2 2026 earnings call highlights, citing record ARR growth. CEO Austin Lauley said new installations were slower amid a choppy consumer backdrop, especially in Latin America, but volumes were 219,000 and portfolio grew 9.4% YoY with stable attrition at 7.5%. CFO Colin Smith noted adjusted EBIT margin outlook above 26% and EUR10m rebrand spend in Q2.
AlphAI scores every news story that mentions VSRPF with an AI model for sentiment and relevance, and aggregates insider trades from Verisure plc/ADR's SEC EDGAR Form 4 filings. Figures refresh continuously.
Verisure reported Q3 2026 results with ARR of €3,712m (+11.8% y/y), Adjusted EBIT of €285m (+13.9% y/y), and Free Cash Flow of €59m. Customer base grew 9.0% y/y to 6.5m. The company expects 2026 ARR growth of 9.0%-9.5% and Adjusted EBIT margin around 26.5%. CEO Austin Lally highlighted strong profitability and cash generation.
3 min readVerisure Plc's stock rose 12% to 10.49 after reports that CVC is considering a potential offer to take the company private. The stock had fallen from its IPO price of 13.25, and analysts' average price target is above current levels. Hellman & Friedman owns 43.6% of Verisure. The broader market is down, contrasting with Verisure's surge.
2 min readChevron is selling mature Gulf of Mexico assets to reduce future cleanup costs and maintenance spending, allowing it to focus on larger projects. Applus+ may sell its vehicle inspection unit for around €1 billion. CVC is exploring a takeover of Swedish-listed Verisure. Cencora will acquire American Oncology Network for up to $2.4 billion, expanding its US cancer care reach.
2 min readGoldman Sachs reduced its price target for Verisure from €15 to €13 but maintained a 'buy' rating. The stock is currently trading at €8.115, reflecting a 40.86% decline year-to-date. The company recently expanded its AI-powered GuardVision Outdoor Video Detector internationally.
1 min readVerisure PLC reported Q2 2026 earnings call highlights, citing record ARR growth. CEO Austin Lauley said new installations were slower amid a choppy consumer backdrop, especially in Latin America, but volumes were 219,000 and portfolio grew 9.4% YoY with stable attrition at 7.5%. CFO Colin Smith noted adjusted EBIT margin outlook above 26% and EUR10m rebrand spend in Q2.
7 min read
